PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mdm2 suppresses tumors by pulling the plug on glycolysis

Mdm2 suppresses tumors by pulling the plug on glycolysis
2014-02-24
(Press-News.org) Cancer cells have long been known to have higher rates of the energy-generating metabolic pathway known as glycolysis. This enhanced glycolysis, a phenomenon known as the Warburg effect, is thought to allow cancer cells to survive the oxygen-deficient conditions they experience in the center of solid tumors. A study in The Journal of Cell Biology reveals how damaged cells normally switch off glycolysis as they shut down and shows that defects in this process may contribute to the early stages of tumor development.

Various stresses can cause cells to cease proliferating and enter an inactive state known as "senescence" that prevents their transformation into tumor cells. In 2005, Hiroshi Kondoh and colleagues found that cells normally limit glycolysis as they enter senescence and that increasing the levels of the glycolytic enzyme PGAM can prevent cells from exiting the cell cycle. PGAM is increased in many tumors, stimulating glycolysis and other important pathways. But how cells regulate PGAM has been unclear.

Working at Kyoto University in Japan, Kondoh and colleagues followed up on their previous work and found that, in response to DNA damage or oncogene expression, PGAM was degraded, thereby inhibiting glycolysis as the cells entered senescence. The enzyme Mdm2 targeted PGAM for degradation in response to these senescence-inducing stresses.

"Mdm2 can clearly, in some cases, act as a tumor suppressor by destabilizing PGAM," says Kondoh. Recent studies have emphasized the importance of PGAM as a therapeutic target for cancer management. Identifying the modulators of PGAM stability might open up new avenues for intervention.

INFORMATION:

Mikawa, T., et al. 2014. J. Cell Biol. doi:10.1083/jcb.201306149.
Kondoh, H., et al. 2005. Cancer Res. 65:177-185.

About The Journal of Cell Biology

The Journal of Cell Biology (JCB) is published by The Rockefeller University Press. All editorial decisions on manuscripts submitted are made by active scientists in conjunction with our in-house scientific editors. JCB content is posted to PubMed Central, where it is available to the public for free six months after publication. Authors retain copyright of their published works, and third parties may reuse the content for non-commercial purposes under a creative commons license. For more information, please visit http://www.jcb.org.

[Attachments] See images for this press release:
Mdm2 suppresses tumors by pulling the plug on glycolysis

ELSE PRESS RELEASES FROM THIS DATE:

Two-pronged approach successfully targets DNA synthesis in leukemic cells

Two-pronged approach successfully targets DNA synthesis in leukemic cells
2014-02-24
A novel two-pronged strategy targeting DNA synthesis can treat leukemia in mice, according to a study in The Journal of Experimental Medicine. Current treatments for acute lymphoblastic leukemia (ALL), an aggressive form of blood cancer, include conventional chemotherapy drugs that inhibit DNA synthesis. These drugs are effective but have serious side effects on normal dividing tissues. In order to replicate, cells must make copies of their DNA, which is made up of building blocks called deoxyribonucleotide triphosphates (dNTPs). Cells can either make dNTPs from scratch ...

Blocking autophagy with malaria drug may help overcome resistance to melanoma BRAF drugs

Blocking autophagy with malaria drug may help overcome resistance to melanoma BRAF drugs
2014-02-24
PHILADELPHIA— Half of melanoma patients with the BRAF mutation have a positive response to treatment with BRAF inhibitors, but nearly all of those patients develop resistance to the drugs and experience disease progression. Now, a new preclinical study published online ahead of print in the Journal of Clinical Investigation from Penn Medicine researchers found that in many cases the root of the resistance may lie in a never-before-seen autophagy mechanism induced by the BRAF inhibitors vermurafenib and dabrafenib. Autophagy is a process by which cancer cells recycle ...

Like mom or dad? Some cells randomly express one parent's version of a gene over the other

Like mom or dad? Some cells randomly express one parents version of a gene over the other
2014-02-24
Cold Spring Harbor, NY – We are a product of our parents. Maybe you have your mother's large, dark eyes, and you inherited your father's infectious smile. Both parents contribute one copy, or allele, of each gene to their offspring, so that we have two copies of every gene for a given trait – one from mom, the other from dad. In general, both copies of a gene are switched on or off as an embryo develops into an adult. The "switching on" of a gene begins the process of gene expression that ultimately results in the production of a protein. Occasionally, a cell will arbitrarily ...

Caring for patients with multiple chronic conditions -- New research and future challenges

2014-02-24
Philadelphia, Pa. (February 21, 2014) – The millions of Americans living with more than one chronic disease are at high risk of poor health outcomes, and account for a disproportionate share of health care costs. A special March supplement to Medical Care presents updates from the Agency for Healthcare Research and Quality's (AHRQ) Multiple Chronic Conditions (MCC) Research Network, formed to address knowledge gaps and research challenges in meeting the complex health care needs of this growing population. The journal is published by Lippincott Williams & Wilkins, a part ...

Nearly half of uninsured children live in immigrant families, reports study in Medical Care

2014-02-24
Philadelphia, Pa. (February 21, 2014) – Children from immigrant families now account for 42 percent of uninsured children in the United States, reports a study in the March issue of Medical Care. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. More than two-thirds of uninsured children with immigrant parents are US citizens, according to an analysis of nationwide survey data by Eric E. Seiber, PhD, of The Ohio State University College of Public Health, Columbus. He writes, "Initiatives to expand coverage or increase Medicaid ...

Preventing suicide should start in a general medical setting

2014-02-24
The mental health conditions of most people who commit suicide remain undiagnosed, even though most visit a primary care provider or medical specialist in the year before they die. To help prevent suicides, health care providers should therefore become more attuned to their patients' mental health state and possible suicide ideation. These are the findings of Brian Ahmedani from the Henry Ford Health System in Detroit, Michigan, in a new study¹ documenting the type and timing of health services sought by Americans who commit suicide. The study is the largest geographically ...

Did you hear the one about the doctor?

2014-02-24
LEBANON, NH (Feb. 24, 2014) – In a study that demonstrates the potential of using social networking sites for research on health and medicine, Dartmouth researchers studied jokes made about doctors posted on Facebook. "Social networking sites, such as Facebook, have become immensely popular in recent years and present a unique opportunity for researchers to eavesdrop on the collective conversation of current societal issues," said Matthew Davis of The Dartmouth Institute of Health Policy & Clinical Practice. In one of the first studies of social networking site conversations ...

Exclusive David Gancberg article in Human Gene Therapy

Exclusive David Gancberg article in Human Gene Therapy
2014-02-24
New Rochelle, NY, February 24, 2014—Over the past three funding stages, the European Commission has invested nearly $475 million in 100 projects in the gene transfer and gene therapy field. David Gancberg, Directorate-General for Research and Innovation, European Commission (Brussels), describes the substantial opportunities for funding to support basic and clinical research in gene and cell therapy to find new treatments for chronic and rare diseases and novel regenerative medicine approaches in a Commentary article in Human Gene Therapy, a peer-reviewed journal from Mary ...

Volcanoes contribute to recent warming 'hiatus'

2014-02-24
LIVERMORE, Calif. -- Volcanic eruptions in the early part of the 21st century have cooled the planet, according to a study led by Lawrence Livermore National Laboratory. This cooling partly offset the warming produced by greenhouse gases. Despite continuing increases in atmospheric levels of greenhouse gases, and in the total heat content of the ocean, global-mean temperatures at the surface of the planet and in the troposphere (the lowest portion of the Earth's atmosphere) have shown relatively little warming since 1998. This so-called 'slow-down' or 'hiatus' has received ...

Personalized medicine best way to treat cancer, study argues

Personalized medicine best way to treat cancer, study argues
2014-02-24
If a driver is traveling to New York City, I-95 might be their route of choice. But they could also take I-78, I-87 or any number of alternate routes. Most cancers begin similarly, with many possible routes to the same disease. A new study found evidence that assessing the route to cancer on a case-by-case basis might make more sense than basing a patient's cancer treatment on commonly disrupted genes and pathways. The study found little or no overlap in the most prominent genetic malfunction associated with each individual patient's disease compared to malfunctions ...

LAST 30 PRESS RELEASES:

Call for papers: 14th Asia-Pacific Conference on Transportation and the Environment (APTE 2025)

A novel disturbance rejection optimal guidance method for enhancing precision landing performance of reusable rockets

New scan method unveils lung function secrets

Searching for hidden medieval stories from the island of the Sagas

Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model

Neuroscience leader reveals oxytocin's crucial role beyond the 'love hormone' label

Twelve questions to ask your doctor for better brain health in the new year

Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes

Study identifies genetic cause for yellow nail syndrome

New drug to prevent migraine may start working right away

Good news for people with MS: COVID-19 infection not tied to worsening symptoms

Department of Energy announces $179 million for Microelectronics Science Research Centers

Human-related activities continue to threaten global climate and productivity

Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued

Unraveling the power and influence of language

Gene editing tool reduces Alzheimer’s plaque precursor in mice

TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies

Twisted Edison: Bright, elliptically polarized incandescent light

Structural cell protein also directly regulates gene transcription

Breaking boundaries: Researchers isolate quantum coherence in classical light systems

Brain map clarifies neuronal connectivity behind motor function

Researchers find compromised indoor air in homes following Marshall Fire

Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality

Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology

'Glass fences' hinder Japanese female faculty in international research, study finds

Vector winds forecast by numerical weather prediction models still in need of optimization

New research identifies key cellular mechanism driving Alzheimer’s disease

Trends in buprenorphine dispensing among adolescents and young adults in the US

Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility

Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity

[Press-News.org] Mdm2 suppresses tumors by pulling the plug on glycolysis